120 related articles for article (PubMed ID: 7821357)
21. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse.
Choi SS; Han EJ; Lee TH; Lee JK; Han KJ; Lee HK; Suh HW
Planta Med; 2002 Sep; 68(9):794-8. PubMed ID: 12357389
[TBL] [Abstract][Full Text] [Related]
22. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered beta-endorphin and morphine or DPDPE in mice.
Suh HH; Tseng LF
Life Sci; 1990; 46(11):759-65. PubMed ID: 2157119
[TBL] [Abstract][Full Text] [Related]
23. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
24. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Lohmann AB; Welch SP
Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
[TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1086-92. PubMed ID: 1545380
[TBL] [Abstract][Full Text] [Related]
26. Antinociceptive mechanisms of dipsacus saponin C administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Son KH; Wie MB; Lee KH; Jung KY; Do JC; Kim YH
Gen Pharmacol; 1996 Oct; 27(7):1167-72. PubMed ID: 8981063
[TBL] [Abstract][Full Text] [Related]
27. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
28. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
29. Effect of diabetes on the antinociceptive effect of beta-endorphin.
Kamei J; Kawashima N; Hitosugi H; Misawa M; Nagase H; Kasuya Y
Brain Res; 1993 Aug; 619(1-2):76-80. PubMed ID: 8374794
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Kim YH
Neuropeptides; 1997 Aug; 31(4):339-44. PubMed ID: 9308021
[TBL] [Abstract][Full Text] [Related]
31. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
Welch SP; Singha AK; Dewey WL
J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070
[TBL] [Abstract][Full Text] [Related]
32. Differential cross-tolerance between analgesia produced by alpha 2-adrenoceptor agonists and receptor subtype selective opioid treatments.
Paul D; Tran JG
Eur J Pharmacol; 1995 Jan; 272(1):111-4. PubMed ID: 7713142
[TBL] [Abstract][Full Text] [Related]
33. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
34. Antisense oligodeoxynucleotide to a delta-opioid receptor given intrathecally blocks i.c.v. administered beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
Life Sci; 1994; 55(7):PL127-31. PubMed ID: 8041224
[TBL] [Abstract][Full Text] [Related]
35. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
36. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
37. The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception.
Kest B; Marek P; Liebeskind JC
Brain Res; 1992 Aug; 589(1):139-42. PubMed ID: 1422813
[TBL] [Abstract][Full Text] [Related]
38. Contrasting actions of intrathecal U50,488H, morphine, or [D-Pen2, D-Pen5] enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat.
Harada Y; Nishioka K; Kitahata LM; Nakatani K; Collins JG
Anesthesiology; 1995 Aug; 83(2):336-43. PubMed ID: 7631956
[TBL] [Abstract][Full Text] [Related]
39. Effects of GABA receptor antagonists injected spinally on antinociception induced by opioids administered supraspinally in mice.
Suh HW; Kim YH; Choi YS; Choi SR; Song DK
Eur J Pharmacol; 1996 Jun; 307(2):141-7. PubMed ID: 8832215
[TBL] [Abstract][Full Text] [Related]
40. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
